The placebo-controlled, randomized trial will include 15,000 adults in 17 countries. Volunteers for the trial are currently being recruited in Australia.
The vaccine, developed by Sanofi Pasteur, is designed to protect at-risk individuals from C. diff infections.
More Articles on Gastroenterology:
Drs. Richard Fedorak, Haili Wang Develop Urine Test for Detection of Colonic Polyps
Study: Thalidomide as Treatment for Pediatric Crohn’s Disease
6 Statistics on GI/Endoscopy Revenue Per Case in Surgery Centers by Number of ORs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
